# DoD PRMRP Focused Program Award

Source: https://welltoldgrants.com/grants/w81xwh-22-prmrp-fpa-dod-prmrp-focused-program-award/  
Official notice: https://www.grants.gov/search-results-detail/338722

> Defense Health Agency Contracting Activity - DHACA offered grants to any type of organization. It expected to make about 5 awards worth $54.0 million in total. Applications closed on August 12, 2022.

| Field | Value |
|---|---|
| Opportunity number | W81XWH-22-PRMRP-FPA |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | Forecast |
| Deadline | August 12, 2022 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | 5 |
| Total funding | $54.0 million |
| Cost sharing | not required |
| Assistance Listings | 12.420 |

## Who can apply

- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

The FY22 PRMRP Focused Program Award (FPA) is intended to optimize research and accelerate solutions to a critical question related to one of the congressionally directed FY22 PRMRP Topic Areas and one of the FY22 PRMRP Strategic Goals through a synergistic, multidisciplinary research program. Key aspects of this award include: Overarching Challenge: FPA applications must describe a unifying, overarching challenge that will be addressed by a set of research projects. The overarching challenge must be relevant to a critical problem or question in the field of research and/or patient care in one of the FY22 PRMRP Topic Areas and one of the FY22 PRMRP Strategic Goals. Research Projects: Applications shall include multiple, distinct research projects led by individual project leaders that address complementary aspects of the overarching challenge. Applicants are strongly encouraged to submit a minimum of four research projects; additional studies are allowed. While individual projects must be capable of standing on their own high scientific merits, they must also be interrelated and synergistic with the other proposed projects and advance a solution beyond what would be possible through individual efforts. The exploration of multiple hypotheses or viewpoints of the same line of questioning is encouraged. This award mechanism is not intended to support a series of research projects that are dependent on the success of one of the other projects. Each project should propose a unique approach to addressing the overarching challenge and be capable of producing research findings with potential to impact the field and/or patient care. Individual research projects may range from exploratory, hypothesis-developing studies through small-scale clinical trials (i.e., up to and including phase 2 or equivalent). There should be a clear intent to progress toward translational/ clinical work over the course of the effort. If an Investigational New Drug (IND) or Investigational Device Exemption (IDE) will be required to support a project that includes some preclinical work to be completed prior to an early-phase (pilot, phase 1, phase 2, or equivalent) clinical trial, then a proposed submission date of the IND or IDE application to the U.S. Food and Drug Administration (FDA) should be included in the application.

## Questions people ask

### Is W81XWH-22-PRMRP-FPA still open?

No. It closed on August 12, 2022. A newer notice is open: HT942526BCRPCREA2, closes November 18, 2026 (11 days left).

### Who can apply for DoD PRMRP Focused Program Award?

Defense Health Agency Contracting Activity - DHACA accepted applications from any type of organization.

### What is the deadline for DoD PRMRP Focused Program Award?

Closed August 12, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

About $54.0 million in total across about 5 awards.

### Who has won Military Medical Research and Development grants before?

The largest recipients over five fiscal years were The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., The Univeristy of Texas M.D. Anderson Cancer Center, The Johns Hopkins University. The program made 5,470 awards worth $6.9 billion in that time.